Teresa Lee

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.

We create the space that enables extraordinary things to happen - Europe’s leading owner, manager and developer of industrial property.

With our investment approach, we invest exclusively in companies that are already creating a sustainable, clean, safe and healthy world for current and future generations. We invest specifically in impact issues, in real change.

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.

Round Hill Ventures (RHV) is Europes leading venture capital firm, supporting the founders who reshape the built environment through technology. Our mission is to be at the forefront of built world technology innovation in Europe. We invest from Late Seed to Series B+ rounds as lead or co-investors. Our unique structure grants us direct access to 200+ real estate private equity professionals with knowledge of the full real estate value chain.